Drug Profile


Alternative Names: Lucelan; Metatone; Teniloxazine; Y 8894

Latest Information Update: 22 Nov 1999

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mitsubishi Pharma Corporation
  • Class Antidepressants; Antiulcers
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Alzheimer's disease; Major depressive disorder

Most Recent Events

  • 22 Nov 1999 No-Development-Reported for Alzheimer's disease in Japan (PO)
  • 22 Nov 1999 No-Development-Reported for Depression in Japan (PO)
  • 09 Jan 1997 Phase-III clinical trials for Depression in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top